"Waking Up" Data in Clinical Workflows with AI - with Mathew Paruthickal of Sanofi
Today's guest is Mathew Paruthickal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi. Founded in 1973, Sanofi is a French multinational pharmaceutical and healthcare company. Sanofi works in the research, development, and manufacturing of pharmaceuticals and vaccines. Mathew joins Emerj Editorial Director Matthew DeMello to explore how life sciences organisations can move from isolated digital tools to orchestrated, interoperable systems and how engineering teams can bake in traceability, auditability, and human-in-the-loop governance from day one. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!
-------- Â
18:13
--------
18:13
From Hiring to Growth and the Future of Workforce Strategy - with Meghna Punhani of Eightfold AI
Today's guest is Meghna Punhani, Chief People Officer at Eightfold AI. Eightfold AI provides an AI-powered platform for talent management, helping organizations optimize hiring, internal mobility, and workforce development. Meghna joins Emerj Editorial Director Matthew DeMello to discuss how HR leaders can adopt AI responsibly to enhance workforce capabilities and drive strategic impact. She also shares practical insights on reengineering HR workflows, leveraging AI for candidate screening and internal mobility, and building human-centered ethical guardrails for AI implementation. This episode is sponsored by Eightfold AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!
-------- Â
35:06
--------
35:06
Copyright Risk in Financial Services and the Rise of Responsible AI – with Lauren Tulloch of CCC
Today's guest is Lauren Tulloch, Vice President and Managing Director at CCC (Copyright Clearance Center). CCC provides collective copyright licensing services for corporate and academic users of copyrighted materials, and, as one can imagine, the advent of AI has exposed a large number of businesses to copyright risks they've never considered before. Today, Lauren joins us to discuss where copyright exposure arises in financial services, from the growth of AI development to more commonplace employee use. With well over a decade at the company, Lauren dives into the urgent need for proactive copyright strategies in financial services, ensuring firms avoid litigation, regulatory scrutiny, and reputational damage, all while maximizing the value of AI. This episode is sponsored by CCC. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
-------- Â
14:08
--------
14:08
Why False Positives Are Costing Banks More Than Fraud - with Suvaleena Paul of Bank of America
Today's guest is Suvaleena Paul, Assistant Vice President and Senior Analyst in Fraud, Innovation, and Analysis at Bank of America. Suvaleena joins Emerj Editorial Director Matthew DeMello to discuss the integration of AI-driven technologies into fraud prevention workflows. She also shares practical insights on improving threat identification speed, fostering cross-team collaboration, and continuously refining AI models to maximize ROI and maintain regulatory compliance. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!
-------- Â
24:51
--------
24:51
Using Artificial Intelligence to Unlock Hidden Insights in Genomic Research - with Dr. Mark Kiel of Genomenon
Today's guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares practical approaches to integrating AI with human curation, improving workflow efficiency, and scaling insights for rare disease diagnosis, trial design, and drug development strategy. This episode is sponsored by Genomenon. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!
The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.
Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption.
Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise
Canada - english